Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Philips Clinical & Medical Affairs Global
- Study ID
- NCT04657523
- Status
- Completed
Conditions
- Non-Alcoholic Fatty Liver Disease
- Non-Alcoholic Steatohepatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Investigational Liver Fat Quantification Software — DEVICEAll subjects enrolled in this study will undergo two abdominal ultrasound examinations using the investigational Liver Fat Quantification feature on the Philips EPIQ Ultrasound System. In addition, all subjects will also undergo one MRI-PDFF examination according to the clinical standard of care.
Study Details
This clinical study will involve performing a series of medical imaging procedures of the abdomen using both ultrasound and MRI modalities in subjects at risk for or already diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD). The primary objective of this clinical study is to evaluate the clinical feasibility of an investigational ultrasound technique for quantifying liver fat by comparing specific ultrasound-derived biomarkers with the liver fat percentage obtained from MRI Proton Density Fat Fraction (MRI-PDFF) measurements. All subjects enrolled in this study will undergo two investigational abdominal ultrasound examinations using the Philips EPIQ Ultrasound System and one MRI PDFF examination according to the clinical standard of care.
Key Dates
- Start date
- Oct 30, 2020
- Status verified
- Oct 2024
- Primary completion
- Jan 18, 2023
- Completion
- Jan 18, 2023
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Investigational Ultrasound Imaging for Liver Fat Quantification
Primary Outcome Measure
Correlation of the Liver Fat Percentage Reported From MRI-PDFF With Measurements Hepatorenal Index (HRI) of Ultrasound Biomarkers for Liver Fat. [ Time Frame: Intra-procedural (1 day) ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Medical Center | Boston | Massachusetts | 02118 | - |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | - |
| Radiology Consultants, Inc | Boardman | Ohio | 44512 | - |
Find similar trials in Boston, MA
Related Studies
- Intermittent Fasting for NAFLD in AdultsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver DiseaseRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)PHASE2 · Recruiting · Marialena Mouzaki · Cincinnati, Ohio